Get started
State Street SPDR S&P Pharmaceuticals ETFState Street SPDR S&P Pharmaceuticals ETFState Street SPDR S&P Pharmaceuticals ETF

State Street SPDR S&P Pharmaceuticals ETF

No trades
OverviewAnalysisNewsCommunityTechnicalsSeasonalsOptions

Chart


Full chart

Key stats


Assets under management (AUM)
—
Fund flows (1Y)
‪102.04 M‬
Dividend yield (indicated)
—
Discount/Premium to NAV
−0.08%
Shares outstanding
—
Expense ratio
—

About State Street SPDR S&P Pharmaceuticals ETF


XPH offers equal-weighted exposure to a narrow selection of US pharmaceutical companies, stretching across all market caps. XPH's weighting scheme causes it to be far less concentrated than the industry, which is dominated by a handful of mega-cap names like J&J, Pfizer and Merck. The fund also introduces a heavy tilt to mid- and small-caps, which makes for a rather volatile fund relative to the industry. Overall, XPH is a solid way to capture a less concentrated version of the pharma market. The index is rebalanced quarterly. Prior to Oct. 31, 2025 the Issuer did not use the branding of State Street in the fund name.

Broaden your horizons with more funds linked to this ETF via country, focus, and more.

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


An exchange-traded fund (ETF) is a collection of assets (stocks, bonds, commodities, etc.) that track an underlying index and can be bought on an exchange like individual stocks.
XPH trades at 56.84 USD today, its price has risen 0.04% in the past 24 hours. Track more dynamics on XPH price chart.
XPH price has fallen by −0.11% over the last month, and its yearly performance shows a 24.49% increase. See more dynamics on XPH price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 2.22% over the last month, showed a 11.89% increase in three-month performance and has increased by 26.16% in a year.
Since ETFs work like an individual stock, they can be bought and sold on exchanges (e.g. NASDAQ, NYSE, EURONEXT). As it happens with stocks, you need to select a brokerage to access trading. Explore our list of available brokers to find the one to help execute your strategies. Don't forget to do your research before getting to trading. Explore ETFs metrics in our ETF screener to find a reliable opportunity.
In some ways, ETFs are safe investments, but in a broader sense, they're not safer than any other asset, so it's crucial to analyze a fund before investing. But if your research gives a vague answer, you can always refer to technical analysis.
Today, XPH technical analysis shows the buy rating and its 1-week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1-month rating XPH shows the buy signal. See more of XPH technicals for a more comprehensive analysis.
No, XPH doesn't pay dividends to its holders.
XPH trades at a premium (0.08%).
Premium/discount to NAV expresses the difference between the ETF’s price and its NAV value. A positive percentage indicates a premium, meaning the ETF trades at a higher price than the calculated NAV. Conversely, a negative percentage indicates a discount, suggesting the ETF trades at a lower price than NAV.